The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study-Reference-Cited by-同舟云学术

The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study

Published:2023-08 Issue: Volume:70 Page:56-62
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Caliskan Yildirim Eda,Atag Elif,Coban Ezgi,Umit Unal Olcun,Celebi Abdussamet,Keser Murat,Uzun Mehmet,Keskinkilic Merve,Tanrikulu Simsek Eda,Sari Murat,Yavuzsen Tugba

Funder

Dokuz Eylül Üniversitesi

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference38 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2022

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci U S A,2001

3. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer;Gennari;Ann Oncol,2021

4. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American Pathologists clinical practice guideline focused update;Wolff;Arch Pathol Lab Med,2018

5. HER2-Low breast cancer: pathological and clinical landscape;Tarantino;J Clin Oncol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis;Frontiers in Oncology;2024-08-29

2. The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer;Medicine;2024-07-26

3. Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study;International Journal of Clinical Oncology;2024-04-30

4. The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study;Breast Cancer Research and Treatment;2024-03-25

5. The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2024-01-19